Neurosurgery

From left to right are Salena Barrett, Nurse Manager; John Fuller, MD, FRACS (Neurosurgeon); Scott Piggott, Chief Radiation Therapist; Michael Izard, MD, FRANZCR (Radiation Oncologist); Angela Hong, MD, FRANZCR (Radiation Oncologist); Kate Tynan, Cancer Services; Michael Grace (Medical Physicist)
At the 15th International Leksell Gamma Knife® Society Meeting, convened May 16-20 in Athens, Greece, members selected Macquarie University Hospital (MUH) to be the host site for the 16th Society Meeting in Sydney, New South Wales, Australia.
“Attendees were very supportive and enthusiastic about Macquarie hosting the meeting,” says John Fuller Macquarie neurosurgeon and Gamma Knife program co-director. “It’s a fantastic privilege and we are already working toward making it the best ever.”
In August, clinicians at MUH performed Australia’s first Gamma Knife® surgery with their new Leksell Gamma Knife® Perfexion™ system. The first radiosurgery patient, a 33-year-old man with multiple brain tumors, underwent a 100-minute treatment and was able to return home the same day, according to Dr. Fuller.
“He was awake during the whole procedure and received only a local anesthetic,” Dr. Fuller reports. “The gentleness of Gamma Knife surgery not only benefits patients, but also extends to their families, our treatment team and the healthcare system as a whole.”
To read more about MUH’s Gamma Knife radiosurgery program, visit http://www.elekta.com/ewavelength.
The Asia Pacific region continues to demonstrate strong growth, fueling demand for healthcare services and technology in the region’s populous countries. South Korea, the world’s 15th largest economy, is among the leaders in Asia Pacific and the site of Elekta’s newest international office located in Bundang, an hour drive from the capital of South Korea, Seoul.
Elekta has a strong foothold in radiosurgery in South Korea, with an installed base of 16 Leksell Gamma Knife®. With increased local presence, Elekta expects to build on its leading position in radiosurgery and strengthen its share of the radiotherapy market, thereby making cancer care available for more people in the country.
“South Korean clinics and medical centers are addressing an increasing demand for healthcare in general, and cancer management in particular,” says Ian Alexander, Executive Vice
President of Elekta’s Asia Pacific Region. “Cancer incidences are rising in concert with the growth of the 65-years and older population, which represents nearly 10 percent of South Korea’s 49 million residents. This new office provides another much-needed channel through which our South Korean customers can satisfy their requirements for cancer care solutions.”
The Asia Pacific region as a whole is increasing its acquisition of Elekta equipment in response to a surge in cancer cases, he adds. “The countries in this region collectively account for an increasingly large percentage of Elekta’s global business.”
The South Korea office is in the process of reinforcing a strong organizational foundation. “These positions will be key in providing the best service and support to existing customers as well as reinforce the growth Elekta is experiencing in Korea,” adds Alexander. Elekta also has Asia Pacific offices in Singapore, India, Hong Kong, Tokyo, Shanghai, Beijing and Australia.

